Angiodynamics (ANGO) Total Non-Current Liabilities (2012 - 2026)

Angiodynamics' Total Non-Current Liabilities history runs 15 years deep, the most recent figure standing at $80.0 million for Q2 2026.

• Quarterly Total Non-Current Liabilities changed 0.3% year-over-year to $80.0 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $80.0 million (changed 0.3% YoY) and the FY2026 annual result came in at $80.0 million, changed 0.3% from the prior year.
• Total Non-Current Liabilities was $80.0 million for Q2 2026 at Angiodynamics, up from $70.6 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $149.8 million in Q2 2023 and bottomed at $61.7 million in Q3 2023.
• A 5-year average of $99.1 million and a median of $94.4 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Peak annual rise in Total Non-Current Liabilities reached 46.89% in 2023, while the deepest fall reached 54.41% in 2023.
• Angiodynamics' Total Non-Current Liabilities stood at $141.2 million in 2022, then slumped by 32.15% to $95.8 million in 2023, then declined by 2.99% to $92.9 million in 2024, then slipped by 17.9% to $76.3 million in 2025, then increased by 4.9% to $80.0 million in 2026.
• Business Quant data shows ANGO's Total Non-Current Liabilities at $80.0 million in Q2 2026, $70.6 million in Q1 2026, and $76.3 million in Q4 2025.